Results 171 to 180 of about 65,609 (259)

Effects of Elevated CO2 on Bean Pod Mottle Virus Infection in Both Incompatible and Compatible Interactions With Phaseolus vulgaris L

Plant, Cell &Environment, EarlyView.
ABSTRACT Plant viruses cause significant crop losses, a situation that could worsen due to anthropogenic activities driving global climate change, one factor of which is the increase in atmospheric CO2 concentration. This study assessed the impact of elevated CO2 concentration (eCO2, 1000 vs. 400 ppm) on two genotypes of common bean (Phaseolus vulgaris
Tiffanie Scandolera, Julie Lintz, Ariane Gratias, Ellea Aboud, Simon Rochoux, Maria V. Préjean, Gilles Chatel Innocenti, Marie Garmier, Gianluca Teano, Juan C. Alvarez‐Diaz, Graham Noctor, Valérie Geffroy, Stéphanie Pflieger   +12 more
wiley   +1 more source

Early diagnosis of progressive multifocal leukoencephalopathy in untreated HIV infection via ultrasensitive PCR testing for JC virus: A case report. [PDF]

IDCases
Nakano K, Kawashima A, Nakamoto T, Nakamichi K, Kuwata R, Abe S, Inoue E, Ando N, Uemura H, Mizushima D, Aoki T, Teruya K, Gatanaga H.   +12 more
europepmc   +1 more source

Trafficking of JC virus-like particles across the blood-brain barrier. [PDF]

Nanoscale Adv, 2021
Ye D, Zimmermann T, Demina V, Sotnikov S, Ried CL, Rahn H, Stapf M, Untucht C, Rohe M, Terstappen GC, Wicke K, Mezler M, Manninga H, Meyer AH.   +13 more
europepmc   +1 more source

The Effectiveness of the Palivizumab Programme in Reducing the Risk of Paediatric Asthma: A Population‐Based Study in Ontario, Canada

Paediatric and Perinatal Epidemiology, EarlyView.
ABSTRACT Background Palivizumab was introduced in Canada in 1998 as a publicly funded programme to reduce respiratory syncytial virus (RSV) disease in high‐risk children. Severe early‐life RSV infections are associated with increased asthma risk. Thus, palivizumab may also indirectly reduce paediatric asthma.
Kimberley A. Foley, Sarah A. Buchan, Dayre McNally, Michelle Dimitris, Sarah Swayze, Jeffrey C. Kwong, Steven Hawken, Sonia Saxena, Dougal Hargreaves, Tiffany Fitzpatrick   +9 more
wiley   +1 more source

JC Virus in Kidney Transplant Population: Are We Cautious Enough? [PDF]

J Clin Med
Pjanic M, Aleckovic-Halilovic M, Basic-Jukic N.   +2 more
europepmc   +1 more source

Early Pathological JC Virus Lesions in a Patient without Any MRI-based Indications. [PDF]

Intern Med, 2021
Sanjo N, Nose Y, Miyamoto S, Shishido-Hara Y, Saito T, Fukuda T, Yamamoto K, Kobayashi D, Yokota T.   +8 more
europepmc   +1 more source

JC Virus Antibody Measurement [PDF]

, 2020
openaire   +1 more source

Diagnostic Insighhts Into JC Virus-Infected Glial Cells: Intraoperative Cytopathological Analysis of Dot-Shaped Inclusions Associated With PML-NBs. [PDF]

Cytopathology
Ujihira N, Doi H, Shishido-Hara Y.
europepmc   +1 more source

A multi-omic investigation of male lower urinary tract symptoms: Potential role for JC virus. [PDF]

PLoS One, 2021
Thomas S, Dunn CD, Campbell LJ, Strand DW, Vezina CM, Bjorling DE, Penniston KL, Li L, Ricke WA, Goldberg TL.   +9 more
europepmc   +1 more source

Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS‐CoV‐2 With ACE2‐Inhibiting Activity Following mRNA Vaccination

Transplant Infectious Disease, EarlyView.
Kidney transplant recipients develop nasal mucosal antibodies after systemic COVID‐19 vaccination, which are able to inhibit binding of SARS‐CoV‐2 to the ACE2 receptor, but at a lower concentration than the general population. ABSTRACT Background Less than 60% of kidney transplant recipients (KTRs) become IgG seropositive for the viral spike (S ...
Vera J. C. H. Koomen, Christa E. van der Gaast‐deJongh, Fred van Opzeeland, Ria Philipsen, Marije C. Baas, A. Lianne Messchendorp, Frederike J. Bemelman, Marcia M. L. Kho, Carla C. Baan, Debbie van Baarle, Jan‐Stephan F. Sanders, Rob van Binnendijk, Gerco den Hartog, Ron T. Gansevoort, Renate G. van der Molen, Luuk B. Hilbrands, Dimitri A. Diavatopoulos   +16 more
wiley   +1 more source